Skip to main content
Insulet Corporation (PODD)
NASDAQ: PODD · IEX Real-Time Price · USD
177.19
+1.24 (0.70%)
At close: May 31, 2024, 4:00 PM
184.00
+6.81 (3.84%)
After-hours: May 31, 2024, 7:09 PM EDT

Insulet Revenue

Insulet had revenue of $1.78B in the twelve months ending March 31, 2024, with 30.17% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $441.70M with 23.35% year-over-year growth. In the year 2023, Insulet had annual revenue of $1.70B with 30.02% growth.

Revenue (ttm)
$1.78B
Revenue Growth
+30.17%
P/S Ratio
6.97
Revenue / Employee
$593,567
Employees
3,000
Market Cap
12.41B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.70B391.80M30.02%
Dec 31, 20221.31B206.50M18.79%
Dec 31, 20211.10B194.40M21.49%
Dec 31, 2020904.40M166.20M22.51%
Dec 31, 2019738.20M174.40M30.93%
Dec 31, 2018563.80M100.00M21.56%
Dec 31, 2017463.80M96.81M26.38%
Dec 31, 2016366.99M103.10M39.07%
Dec 31, 2015263.89M32.57M14.08%
Dec 31, 2014231.32M-15.76M-6.38%
Dec 31, 2013247.08M35.72M16.90%
Dec 31, 2012211.37M59.11M38.83%
Dec 31, 2011152.26M55.29M57.02%
Dec 31, 201096.97M30.93M46.85%
Dec 31, 200966.03M29.97M83.12%
Dec 31, 200836.06M22.69M169.66%
Dec 31, 200713.37M9.71M265.06%
Dec 31, 20063.66M3.61M7,226.00%
Dec 31, 200550.00K--
Dec 31, 20040--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG & Co. KGaA 21.17B
Viatris 15.36B
DaVita 12.34B
Incyte 3.77B
United Therapeutics 2.50B
Royalty Pharma 2.24B
Medpace Holdings 1.96B
Sarepta Therapeutics 1.40B
Revenue Rankings

PODD News

More News